MoonLake Immunotherapeutics - Ordinary Shares - Class A

NASDAQ:MLTX 4:00:00 PM EDT

43.25

+2.23 (+5.44%)

4:01:49 PM EDT: $43.25 0.00 (0.00%)

MoonLake Immunotherapeutics - Ordinary Shares - Class A Stock, NASDAQ:MLTX

Dorfstrasse 29, 52nd floor, Zug, Zug 6300

Switzerland

Phone: +41.510.80.22

Number of Employees: 50

http://www.moonlaketx.com

Description

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.